New Research in Knee OA Management: What the Evidence Says Now

Knee osteoarthritis affects a large proportion of patients in outpatient orthopedic practice. The research on conservative management has matured considerably over the past several years. Here is what the current evidence supports, what has been displaced, and the clinical takeaways most relevant to practice.

Exercise Remains the Core Intervention

The evidence for exercise in knee OA has not weakened — it has strengthened. Systematic reviews and guidelines from OARSI and NICE continue to list therapeutic exercise as a first-line treatment. Both strengthening and aerobic exercise show benefit for pain and function, with effects comparable to NSAIDs in several head-to-head comparisons.

The key clinical point: dose and adherence matter more than modality. Resistance training, cycling, walking, and aquatic exercise all produce meaningful gains. The common mistake is undertreating: prescribing low loads or limited volume because patients are in pain. Graded loading with progression is appropriate and evidence-supported even in moderate-to-severe OA.

The Arthroscopy Evidence Has Solidified

The case against routine arthroscopy for knee OA is now well-established. High-quality trials, including the METEOR trial (Katz et al., 2013) and the FIDELITY trial (Sihvonen et al., 2013), found no significant benefit of arthroscopic partial meniscectomy or debridement over sham surgery or conservative care for OA-related symptoms. More recent data has reinforced this position. Arthroscopy is not indicated for OA-related pain in the absence of a clear mechanical lesion such as a locked joint or a specific, repairable structural finding. PTs should be comfortable discussing this with patients who have been told surgery is their only option.

Load Management and Body Weight

Body weight reduction remains one of the strongest modifiers of knee OA outcomes. A 10% reduction in body weight produces clinically meaningful improvements in pain and function, with greater weight loss producing greater symptom improvement in a dose-response relationship (Atukorala et al., 2016; Chu et al., 2018). The mechanism is partly biomechanical and partly systemic: adipose tissue drives inflammatory mediators that contribute to cartilage breakdown. For patients with overweight or obesity, integrating weight management into the plan of care is not peripheral to OA treatment — it is central.

Load management has also evolved. Emerging data suggests complete activity avoidance is counterproductive. Structured, graded activity performed within tolerable symptoms is preferred over rest. The goal is not “no pain” during activity but rather manageable, expected soreness that settles within 24 hours.

Injections: Revised Expectations

Intra-articular corticosteroid injections provide short-term pain relief but have limited durability beyond four to six weeks, and a randomized trial found repeated injections associated with cartilage volume loss compared to saline (McAlindon et al., 2017). Most guidelines now recommend limiting corticosteroid frequency. Hyaluronic acid injections have mixed evidence; OARSI conditionally recommends against them in most patients (Sabha & Hochberg, 2022). Platelet-rich plasma remains investigational for knee OA: some meta-analyses report clinically meaningful short-term gains (Bensa et al., 2025), while a large placebo-controlled trial found no benefit over saline on pain or cartilage volume (Bennell et al., 2021) — the evidence is not consistent enough to recommend it broadly. PTs should be able to have informed conversations with patients asking about these options.

Central Sensitization in Knee OA

A growing body of research highlights that a subset of knee OA patients present with features of central sensitization: widespread pain, hyperalgesia, and poor correlation between structural findings and symptoms (Hochman et al., 2013; Zolio et al., 2021). For these patients, interventions targeting pain neuroscience, graded exposure, and activity pacing may be more effective than biomechanically-focused exercise alone. This does not change the overall evidence base for exercise, but it adds a dimension to clinical reasoning — particularly for patients who plateau early or respond poorly to standard protocols. Screening for central sensitization features should be part of the initial assessment for patients with disproportionate pain presentations.

Clinical Takeaways

• Load progressively. OA patients tolerate and benefit from strengthening more than many clinicians assume.
• Address weight when relevant — it is a primary clinical variable, not a secondary concern.
• Be prepared to explain why arthroscopy is not indicated for most OA presentations.
• Limit corticosteroid injection frequency and have updated conversations with patients asking about PRP.
• Screen for central sensitization in patients with disproportionate pain or early plateau.
• Education and self-management support improve outcomes independent of exercise dose.

The evidence continues to support a confident, exercise-forward approach to knee OA. The clinical task is applying it consistently and adjusting for the patients who do not follow the expected course.

References

• Arden NK, Perry TA, Bannuru RR, et al. Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines. Nat Rev Rheumatol. 2021;17(1):59-66.
• Atukorala I, Makovey J, Lawler L, et al. Is There a Dose-Response Relationship Between Weight Loss and Symptom Improvement in Persons With Knee Osteoarthritis? Arthritis Care Res (Hoboken). 2016;68(8):1106-1114.
• Bennell KL, Paterson KL, Metcalf BR, et al. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial. JAMA. 2021;326(20):2021-2030.
• Bensa A, Previtali D, Sangiorgio A, et al. PRP Injections for the Treatment of Knee Osteoarthritis: The Improvement Is Clinically Significant and Influenced by Platelet Concentration: A Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2025;53(3):749-760.
• Chu IJ, Lim AY, Ng CL. Effects of meaningful weight loss beyond symptomatic relief in adults with knee osteoarthritis and obesity: a systematic review and meta-analysis. Obes Rev. 2018;19(11):1597-1607.
• Gray B, Gibbs A, Bowden JL, et al. Appraisal of quality and analysis of the similarities and differences between osteoarthritis Clinical Practice Guideline recommendations: A systematic review. Osteoarthritis Cartilage. 2024;32(6):655-668.
• Hochman JR, Davis AM, Elkayam J, et al. Neuropathic pain symptoms on the modified painDETECT correlate with signs of central sensitization in knee osteoarthritis. Osteoarthritis Cartilage. 2013;21(9):1236-1242.
• Katz JN, Brophy RH, Chaisson CE, et al. Surgery versus physical therapy for a meniscal tear and osteoarthritis. N Engl J Med. 2013;368(18):1675-1684.
• McAlindon TE, LaValley MP, Harvey WF, et al. Effect of Intra-articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2017;317(19):1967-1975.
• Sabha M, Hochberg MC. Non-surgical management of hip and knee osteoarthritis; comparison of ACR/AF and OARSI 2019 and VA/DoD 2020 guidelines. Osteoarthr Cartil Open. 2022;4(1):100232.
• Sihvonen R, Paavola M, Malmivaara A, et al. Arthroscopic partial meniscectomy versus sham surgery for a degenerative meniscal tear. N Engl J Med. 2013;369(26):2515-2524.
• Weng Q, Goh SL, Wu J, et al. Comparative efficacy of exercise therapy and oral non-steroidal anti-inflammatory drugs and paracetamol for knee or hip osteoarthritis: a network meta-analysis of randomised controlled trials. Br J Sports Med. 2023;57(15):990-996.
• Zolio L, Lim KY, McKenzie JE, et al. Systematic review and meta-analysis of the prevalence of neuropathic-like pain and/or pain sensitization in people with knee and hip osteoarthritis. Osteoarthritis Cartilage. 2021;29(8):1096-1116.